OMX Copenhagen PI
1.331,50
PKT
-3,27
PKT
-0,25
%
Werbung
Analysen zu OMX Copenhagen PI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
15.12.22 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
13.12.22 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
12.12.22 | A.P. Moeller - Maersk A-S (B) Underweight | Barclays Capital | |
07.12.22 | Novo Nordisk Buy | Deutsche Bank AG | |
25.11.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.11.22 | Novo Nordisk Overweight | Barclays Capital | |
08.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.22 | Novo Nordisk Buy | Deutsche Bank AG | |
03.11.22 | Novo Nordisk Neutral | Credit Suisse Group | |
03.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.11.22 | Novo Nordisk Buy | Deutsche Bank AG | |
02.11.22 | A.P. Moeller - Maersk A-S (B) Buy | UBS AG | |
02.11.22 | Novo Nordisk Sell | UBS AG | |
02.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
02.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
24.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.22 | Novo Nordisk Buy | Deutsche Bank AG | |
14.10.22 | Novo Nordisk Overweight | Barclays Capital | |
07.10.22 | Novo Nordisk Buy | Deutsche Bank AG | |
04.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.10.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.10.22 | Novo Nordisk Overweight | Barclays Capital | |
21.09.22 | Novo Nordisk Buy | Deutsche Bank AG | |
05.09.22 | A.P. Moeller - Maersk A-S (B) Underweight | Barclays Capital | |
23.08.22 | Novo Nordisk Sell | UBS AG | |
22.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
17.08.22 | Novo Nordisk Sell | UBS AG | |
15.08.22 | Novo Nordisk Overweight | Barclays Capital | |
05.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.08.22 | Novo Nordisk Buy | Deutsche Bank AG | |
05.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
04.08.22 | Novo Nordisk Neutral | Credit Suisse Group | |
04.08.22 | Novo Nordisk Overweight | Barclays Capital | |
04.08.22 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
04.08.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
18.07.22 | Novo Nordisk Overweight | Barclays Capital | |
14.07.22 | Novo Nordisk Outperform | Bernstein Research | |
13.07.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |